<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03046147</url>
  </required_header>
  <id_info>
    <org_study_id>KBM-IS-Bone</org_study_id>
    <nct_id>NCT03046147</nct_id>
  </id_info>
  <brief_title>The Effect of Roux-en-Y Gastric Bypass on Bone Turnover</brief_title>
  <official_title>Bone Mineral Density and Markers of Bone Turnover After Roux-en-Y Gastric Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bone mineral density (BMD) is decreased after Roux-en-Y gastric bypass (RYGB) but whether
      RYGB induces changes in BMD beyond adaptation to major weight loss is not known. We aim to
      investigate BMD changes in weight bearing (hip, lumbal columna) and in non-weight bearing
      (forearm) regions before and after maximal weight loss at 1 year and after weight
      stabilisation at 4 years after RYGB. Moreover, plasma markers of bone turnover will be
      studied at fasting and during oral glucose tolerance test.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in bone mineral density of non-weight bearing bone</measure>
    <time_frame>1 year, 4 years</time_frame>
    <description>DXA scans of forearm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in bone mineral density of weightbearing bone</measure>
    <time_frame>1 year, 4 years</time_frame>
    <description>DXA scans of hip and lumbal columna</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma markers of bone turnover</measure>
    <time_frame>1 week, 3 months, 1 year, 4 years</time_frame>
    <description>At fasting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma markers of bone turnover</measure>
    <time_frame>3 months, 1 year, 4 years</time_frame>
    <description>during OGTT</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Gastric Bypass Surgery</condition>
  <condition>Obesity</condition>
  <condition>Bone Loss</condition>
  <arm_group>
    <arm_group_label>RYGB patients with preoperative type diabetes</arm_group_label>
    <description>Recruited from a previously investigated cohort (NCT 01202526)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RYGB patients with preoperative normal glucose tolerance</arm_group_label>
    <description>Recruited from a previously investigated cohort (NCT 01202526)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Roux-en-Y gastric bypass</intervention_name>
    <description>Roux-en-Y gastric bypass surgery for morbid obesity</description>
    <arm_group_label>RYGB patients with preoperative type diabetes</arm_group_label>
    <arm_group_label>RYGB patients with preoperative normal glucose tolerance</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be recruited from a previously investigated cohort of 20 subjects
        undergoing Roux-en-Y gastric bypass surgery (NCT 01202526). The previous study aimed at
        investigating acute and long term changes in insulin sensitivity and secretion, whereas the
        present follow-up study investigates changes in bone metabolism as the primary outcome.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participation in previos study ((NCT 01202526)

        Exclusion Criteria:

          -  Treatment of osteoporosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kirstine N Bojsen-Møller, MD, PhD</last_name>
    <phone>4538626371</phone>
    <email>kirstine.bojsen-moeller@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Copenhagen University hospital Hvidovre</name>
      <address>
        <city>Copenhagen</city>
        <zip>2820</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirstine N Bojsen-Møller, MD, PhD</last_name>
      <phone>4538626371</phone>
      <email>Kirstine.bojsen-moeller@regionh.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2017</study_first_submitted>
  <study_first_submitted_qc>February 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2017</study_first_posted>
  <last_update_submitted>February 6, 2017</last_update_submitted>
  <last_update_submitted_qc>February 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Kirstine Nyvold Bojsen-Moeller</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

